At the CCIL, we’re partnering with the nation’s leading clinical institutions to exchange knowledge and move toward the common goal of a cancer-free future. By gaining and sharing new approaches, we build upon our engineering and research eminence to develop transformative, holistic technological advances in cancer treatment.
The University of Illinois and Carle have formed a biomedical research alliance to foster medical discoveries, improve student educational opportunities, enhance access to clinical and translational research trials for patients in downstate Illinois, encourage the recruitment of specialty physicians, and provide an environment that supports collaboration. Illinois and Carle researchers share space in the new Biomedical Research Center at the Mills Breast Cancer Institute in Urbana, working jointly to address cancer health.
The BRC brings Carle Health System physicians and CCIL investigators together to work side-by-side on translational science — driving entrepreneurship and bringing lab discoveries to clinical practice. Located on the third floor of the Mills Breast Cancer Institute, this partnership creates a unique laboratory setting where basic sciences research is translated to real-world healthcare to create innovative solutions in diagnostics, imaging, materials, and drug delivery.
The University of Illinois and Mayo Clinic have a strategic alliance to promote a broad spectrum of collaborative research, the development of new technologies and clinical tools, and the design and implementation of novel education programs.